Literature DB >> 17112790

lyl-1 and tal-1/scl, two genes encoding closely related bHLH transcription factors, display highly overlapping expression patterns during cardiovascular and hematopoietic ontogeny.

Sébastien Giroux1, Anna-Lila Kaushik, Claude Capron, Ali Jalil, Charikleia Kelaidi, Fred Sablitzky, Dominique Dumenil, Olivier Albagli, Isabelle Godin.   

Abstract

The TAL-1/SCL and LYL-1 genes encode two closely related basic helix-loop-helix transcription factors involved in child T-acute lymphoblastic leukemia through chromosomal rearrangements and transcriptional deregulation. During ontogeny, Tal-1/SCL is required for hematopoietic cell generation, both in the yolk sac, where erythro-myeloid cells are first produced, then in the intra-embryonic compartment, where hematopoietic stem cells independently arise. We describe here the expression pattern of lyl-1 in mouse embryos from 7 to 14 days post coitus using in situ hybridization, as well as beta-Galactosidase (beta-Gal) expression in lyl-1-lacZ knock-in embryos, which express a C-terminally truncated Lyl-1 protein fused to the beta-Galactosidase (Lyl-1Delta/beta-Gal). In addition, we compare lyl-1 expression pattern with that of tal-1/scl. Similar to Tal-1/SCL, Lyl-1 mRNA expression occurs in the developing cardiovascular and hematopoietic systems. However, contrary to tal-1/scl, lyl-1 is not expressed in the developing nervous system. In lyl-1-lacZ knock-in heterozygous and homozygous embryos, beta-Gal expression completely correlates with Lyl-1 mRNA expression in the intra-embryonic compartment and is present: (1) in the developing hematopoietic system, precisely where hematopoietic stem cells emerge, and thereafter in the fetal liver; (2) in the developing vascular system; and (3) in the endocardium. In contrast, whereas Lyl-1 mRNA is expressed in yolk sac-derived endothelial and hematopoietic cells, Lyl-1Delta/beta-Gal is either absent or poorly expressed in these cell types, thus differing from Tal-1/SCL, which is highly expressed there at both mRNA and protein levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17112790     DOI: 10.1016/j.modgep.2006.10.004

Source DB:  PubMed          Journal:  Gene Expr Patterns        ISSN: 1567-133X            Impact factor:   1.224


  13 in total

1.  Genome-wide identification of TAL1's functional targets: insights into its mechanisms of action in primary erythroid cells.

Authors:  Mira T Kassouf; Jim R Hughes; Stephen Taylor; Simon J McGowan; Shamit Soneji; Angela L Green; Paresh Vyas; Catherine Porcher
Journal:  Genome Res       Date:  2010-06-21       Impact factor: 9.043

2.  Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.

Authors:  Irene Homminga; Maartje J Vuerhard; Anton W Langerak; Jessica Buijs-Gladdines; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

3.  Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis.

Authors:  Nathan J Palpant; Yuliang Wang; Brandon Hadland; Rebecca J Zaunbrecher; Meredith Redd; Daniel Jones; Lil Pabon; Rajan Jain; Jonathan Epstein; Walter L Ruzzo; Ying Zheng; Irwin Bernstein; Adam Margolin; Charles E Murry
Journal:  Cell Rep       Date:  2017-08-15       Impact factor: 9.423

Review 4.  E proteins and the regulation of early lymphocyte development.

Authors:  Renée F de Pooter; Barbara L Kee
Journal:  Immunol Rev       Date:  2010-11       Impact factor: 12.988

5.  Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease.

Authors:  Scott Smemo; Luciene C Campos; Ivan P Moskowitz; José E Krieger; Alexandre C Pereira; Marcelo A Nobrega
Journal:  Hum Mol Genet       Date:  2012-04-27       Impact factor: 6.150

6.  A new allele of Lyl1 confirms its important role in hematopoietic stem cell function.

Authors:  George P Souroullas; Margaret A Goodell
Journal:  Genesis       Date:  2011-05-31       Impact factor: 2.487

7.  Adult hematopoietic stem and progenitor cells require either Lyl1 or Scl for survival.

Authors:  George P Souroullas; Jessica M Salmon; Fred Sablitzky; David J Curtis; Margaret A Goodell
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

8.  Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.

Authors:  Virginie Deleuze; Rawan El-Hajj; Elias Chalhoub; Christiane Dohet; Valérie Pinet; Philippe Couttet; Danièle Mathieu
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

9.  LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.

Authors:  Stephen Smith; Rati Tripathi; Charnise Goodings; Susan Cleveland; Elizabeth Mathias; J Andrew Hardaway; Natalina Elliott; Yajun Yi; Xi Chen; James Downing; Charles Mullighan; Deborah A Swing; Lino Tessarollo; Liqi Li; Paul Love; Nancy A Jenkins; Neal G Copeland; Mary Ann Thompson; Yang Du; Utpal P Davé
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) GeneExpression in Egyptian Patients with AcuteMyeloid Leukemia.

Authors:  Nadia El-Menshawy; Doaa Shahin; Hayam Fathi Ghazi
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.